08:00 , Dec 3, 2007 |  BC Week In Review  |  Company News

Beijing Med-Pharm, Novartis sales and marketing update

NVS's Shanghai Novartis Trading Ltd. subsidiary granted BJGP exclusive rights to market and distribute Enablex darifenacin in China for 10 years following approval from The Chinese State Food and Drug Administration (SFDA). BJGP will be...
08:00 , Nov 19, 2007 |  BioCentury  |  Finance

NASDAQ Biotech changes

NASDAQ Biotech changes Company added 11/16 cls Wk chg Beijing Med-Pharm (BJGP) $9.59 -8% Cadence (CADX) $13.21 -5% Eurand (EURX) $12.55 -6% Halozyme (HALO) $8.17 5% Obagi Medical (OMPI) $19.71 -6% Orexigen (OREX) $15.57 3%...
07:00 , Oct 15, 2007 |  BC Week In Review  |  Company News

Beijing Med-Pharm management update

Beijing Med-Pharm Corp. (BJGP), Plymouth Meeting, Penn.   Business: Supply/Service   Hired: Yanping Zhao as corporate VP, formerly VP, executive director and chief representative of the Beijing office at China Biopharmaceutical Ltd.  ...
07:00 , Oct 8, 2007 |  BC Week In Review  |  Company News

Beijing Med-Pharm, Hong Kong Fly International Health Care Ltd., Sunstone Pharmaceutical Co. Ltd. deal

BJGP will acquire from Hong Kong Fly the 51% of Sunstone it does not already own for 8 million BJGP shares worth $92.7 million based on BJGP's close of $11.59 on Sept. 27, the last...
07:00 , Jul 23, 2007 |  BC Week In Review  |  Company News

Beijing Med-Pharm, Ethypharm deal

Ethypharm's Shanghai Ethypharm Pharmaceutical Co. Ltd. subsidiary granted BJGP exclusive rights to market and distribute ondansetron Flashtab in China. Ethypharm will be responsible for getting regulatory approval of the orally disintegrating formulation of ondansetron in...
07:00 , Jul 16, 2007 |  BC Week In Review  |  Company News

KV Pharmaceutical, Beijing Med-Pharm deal

BJGP acquired exclusive rights to market and distribute KVA's Clindesse clindamycin in China to treat bacterial vaginosis. KVA markets the single-application vaginal cream for the indication in the U.S. Clindesse is in an undisclosed stage...
07:00 , Jun 25, 2007 |  BC Week In Review  |  Company News

Beijing Med-Pharm, Lotus Healthcare Inc. sales and marketing update

BJGP will sell and promote Lotus's Galake dihydrocodeine/paracetamol in China to treat pain. Beijing Med-Pharm Corp. (BJGP), Plymouth Meeting, Penn.   Lotus Healthcare Inc. , Hong Kong, China   Business: Neurology  ...
07:00 , Apr 2, 2007 |  BC Week In Review  |  Company News

Beijing Med-Pharm, Shanghai Rongheng Pharmaceutical Co. Ltd. deal

BJGP, a provider of marketing services in China, will acquire a 63.3% stake in Rongheng, which distributes drugs in Shanghai. BJGP announced its plans to acquire a majority stake in Rongheng earlier this year (see...
08:00 , Jan 22, 2007 |  BC Week In Review  |  Company News

Beijing Med-Pharm, Shanghai Rongheng Pharmaceutical Co. Ltd. deal

Chinese marketing services company BJGP plans to acquire a majority stake in Rongheng, which distributes drugs in Shanghai. BGJP expects the deal to close by the end of 3Q07. Beijing Med-Pharm Corp. (BJGP), Plymouth Meeting,...
08:00 , Dec 18, 2006 |  BC Week In Review  |  Company News

Cephalon, Beijing Med-Pharm deal

BJGP will develop and register CEPH's Fentora fentanyl effervescent buccal tablet (FEBT) in China to treat breakthrough pain in opioid-tolerant cancer patients. BJGP plans to conduct a Chinese registration trial next year, and CEPH hopes...